Key Pathogenic Factors in Coronavirus Disease 2019–Associated Coagulopathy and Acute Lung Injury Highlighted in a Patient With Copresentation of Acute Myelocytic Leukemia: A Case Report
暂无分享,去创建一个
B. Sullenger | B. Kraft | L. Que | S. Nair | J. Levy | Ibtehaj A. Naqvi | Lingye Chen | S. Morrison | Lyra B. Olson | Daniel J. Turner
[1] J. Aguado,et al. Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignancies , 2020, European journal of haematology.
[2] R. Gale,et al. Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission , 2020, Leukemia.
[3] Jianfeng Zhou,et al. Clinical characteristics of hematological patients concomitant with COVID‐19 , 2020, Cancer science.
[4] V. García-Gutiérrez,et al. Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19 , 2020, Bone Marrow Transplantation.
[5] I. Amit,et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 , 2020, Nature Medicine.
[6] M. Konopleva,et al. Treating Leukemia in the Time of COVID-19 , 2020, Acta Haematologica.
[7] L. Galli,et al. Favourable outcome of coronavirus disease 2019 in a 1‐year‐old girl with acute myeloid leukaemia and severe treatment‐induced immunosuppression , 2020, British journal of haematology.
[8] J. Connors,et al. COVID-19 and its implications for thrombosis and anticoagulation , 2020, Blood.
[9] R. Woods,et al. Neutrophil extracellular traps in COVID-19. , 2020, JCI insight.
[10] F. Frigieri,et al. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia , 2020, Journal of Thrombosis and Thrombolysis.
[11] A. Raza,et al. Rewriting the rules for care of MDS and AML patients in the time of COVID-19 , 2020, Leukemia Research Reports.
[12] M. Radic,et al. Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19 , 2020, Frontiers in Pharmacology.
[13] Yan Zhao,et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 , 2020, Journal of Infection.
[14] A. Wolberg,et al. Fibrinogen, red blood cells, and factor XIII in venous thrombosis , 2015, Journal of thrombosis and haemostasis : JTH.
[15] P. Chiusolo,et al. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment , 2005, Journal of thrombosis and haemostasis : JTH.